Clinical Trial: Epigenetic Modulation in Relapsed/Refractory Follicular Lymphoma and Marginal Zone Lymphoma
Sponsor and Collaborators
Duke University
Celgene Corporation
Contact
Contact: Donna Adams, ANP
(919) 668-4716
[email protected]
Contact: Patricia Davis, RN
(919) 668-1026
[email protected]
Principal Investigator
Anne W. Beaven, MD Duke University Medical Center Durham, NC USA
ClinicalTrials.gov Identifier
NCT01121757
Please login or register first to view this content.
Enjoying our content?
Thanks for visiting Oncology Nurse Advisor. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Oncology Nurse Advisor. Register for free and gain unlimited access to:
- Clinical Updates
- Evidence-Based Guidance
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Please login or register first to view this content.